Back to Rheumatology
Rheumatologyv2009Evidence-Based

Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP)

Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically CRP. ASAS-endorsed disease activity score for monitoring AS treatment response.

Clinical Input Parameters

scale
Range: 0 — 10 scale
scale
Range: 0 — 10 scale
scale
Range: 0 — 10 scale
scale
Range: 0 — 10 scale
mg/L
Range: 0 — 300 mg/L
Clinical Assessment
Awaiting Parameters
asdas crp score
—score
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ASDAS-CRP = 0.12 × Back Pain + 0.06 × Duration of Morning Stiffness + 0.11 × Patient Global + 0.07 × Peripheral Pain/Swelling + 0.58 × Ln(CRP+1). Cut-offs: <1.3 (inactive), 1.3-2.1 (moderate), 2.1-3.5 (high), >3.5 (very high).

Clinical Pearls & Practice Notes

  • ASDAS-CRP is the preferred version over ASDAS-ESR due to better discriminatory ability and lower variability.
  • All patient-reported measures (back pain, morning stiffness, patient global, peripheral pain) are assessed on a 0-10 numerical rating scale.
  • The score is endorsed by the Assessment of SpondyloArthritis international Society (ASAS) and is the recommended outcome measure for clinical trials.
  • Clinically important improvement is defined as a change ≥1.1 units, and major improvement as a change ≥2.0 units.
  • The score should be calculated regularly to monitor treatment response and guide therapeutic decisions.
  • CRP values should be obtained using standardized laboratory methods, with results reported in mg/L.
  • The natural logarithm of (CRP+1) is used to normalize the distribution and prevent issues with zero values.

Evidence & Literature Citations

  1. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870.
  2. van der Heijde D, Lie E, Kvien TK, Sieper J, van den Bosch F, Listing J, Braun J, Landewé R. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826.
  3. Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594.

Score Interpretation Ranges

Inactive Disease0 – 1.3 pts

Inactive ankylosing spondylitis

Moderate Disease Activity1.3 – 2.1 pts

Moderate ankylosing spondylitis activity

High Disease Activity2.1 – 3.5 pts

High ankylosing spondylitis activity

Very High Disease Activity3.5 – 10 pts

Very high ankylosing spondylitis activity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.